In addition to their improved tropism for the target tissues ... The company is proceeding with additional capsid campaigns derived from AAV9, AAV5, and other AAV serotypes to identify novel ...

A recombinant AAV9 capsid shell able to deliver payload across the blood-brain barrier and into the nervous system and many other tissues · Self-complementary (sc) AAV DNA technology, featuring ...